Greater Los Angeles Chapter

www.lls.org/los

Local Contacts & Leadership


Greater Los Angeles

6033 West Century Blvd. Suite 300
Los Angeles, CA 90045

(310) 342-5800 (phone)

Santa Barbara

1525 State Street Suite 205
Santa Barbara, CA 93101

(805) 884-1883 (phone)

Olivia Gertz, Executive Director
(310) 846-4732 or
olivia.gertz@lls.org

Tricia Jarmer, Patient Services Manager
(310) 846-4704 or
tricia.jarmer@lls.org

Board of Trustees

  • Patricia Flynn, President

  • Javier Rivera Esq., Vice President

  • Virginia Garner, Secretary

  • Neil Gillespie, Treasurer
  • Branka V. Olson, AIA, CID, Patient Services Co-Chair
    & National BOR (Voting member)
  • Dr. Cecilia Fu, Patient Services Co-Chair

  • Peter R. Duchesneau, Partner, Immediate Past President

  • Marina Contreras, Trustee

  • Janet Franklin, MD, MPH, Trustee

  • Jeanne Brown Gardner, Trustee

  • Timothy Hooten, Trustee

  • Sean J. Horvath, Trustee

  • Brett Modesti, Trustee

  • David Albert Pierce, Trustee

  • Michael Schneider, Trustee

  • Jayne Staley, Trustee

  • Amanda M. Termuhlen, MD, Trustee


About The Greater Los Angeles Chapter

The Leukemia & Lymphoma Society's Greater Los Angeles Chapter serves residents who have been touched by one of the blood cancers: leukemia, lymphoma and myeloma. The chapter serves the Los Angeles, Ventura, Santa Barbara and San Luis Obispo counties.

Team In Training
(310) 342-5842 or www.teamintraining.org/los

School & Youth Programs (310) 342-5843 or www.schoolandyouth.org/los

Light The Night (310) 342-5841 or www.lightthenight.org/los


Man & Woman of the Year
(310) 846-4720 or
www.mwoy.org/los


About The Leukemia & Lymphoma Society

The Leukemia & Lymphoma Society (LLS), based in White Plains, NY, is the world's largest voluntary health organization dedicated to funding blood cancer research, education and patient services. LLS's mission is to cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. Since it was founded in 1949, LLS has invested more than $750 million in research specifically targeting blood cancers.

last updated on Wednesday, May 08, 2013
btn_sharethis